GW501516

GW501516, commonly known as Cardarine, is a selective agonist of the peroxisome proliferator-
activated receptor delta (PPARδ). It gained attention for its potential applications in improving

endurance, enhancing fat metabolism, and promoting overall metabolic health. While it has been studied
for its positive effects on exercise performance and metabolism, it’s important to note that the use of
Cardarine as a performance enhancer is controversial, and its safety and legality have been subjects of
debate.
Cardarine works by activating PPARδ, a nuclear receptor that plays a role in various physiological
processes, including lipid metabolism and energy homeostasis. When activated, PPARδ influences the
expression of genes involved in fatty acid oxidation and energy expenditure. This mechanism has led to
interest in Cardarine for its potential benefits in enhancing endurance and fat burning.
Research studies on Cardarine have primarily focused on its effects on metabolism, exercise
performance, and overall metabolic health. It’s important to note that while some studies suggest positive
outcomes, the overall body of research on Cardarine is not as extensive or well-established as that of
more conventional performance-enhancing substances.
1. Effects on Endurance:

• A study published in the journal “Cell Metabolism” (2007) investigated the
effects of PPARδ activation, including the use of Cardarine, on endurance
performance in mice. The study found that mice treated with a PPARδ agonist
demonstrated increased endurance, improved running capacity, and enhanced
oxidative metabolism in skeletal muscles.
• Another study published in “PLoS One” (2013) explored the impact of Cardarine
on endurance capacity in sedentary mice. The results indicated an improvement
in endurance performance, suggesting a potential role for Cardarine in
promoting aerobic exercise capacity.

2. Metabolic Benefits:

A study published in the “Journal of Biological Chemistry” (2009) investigated the effects of Cardarine
on lipid metabolism in cultured human cells. The study suggested that Cardarine could enhance fatty acid
oxidation and improve lipid profile, indicating potential benefits for metabolic health.
In a study published in the “Journal of Medicinal Chemistry” (2004), researchers explored the role of
PPARδ agonists, including Cardarine, in regulating glucose metabolism. The study suggested that PPARδ
activation could have positive effects on glucose homeostasis and insulin sensitivity.
Dosages range from 5mg to 25mg for an adult with a weight of 200lbs